Robert A. Lenz's most recent trade in LB Pharmaceuticals Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LB Pharmaceuticals Inc | Robert A. Lenz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Robert Lenz A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2026 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |